Regencell Bioscience Holdings Limited
- RGC
- NASDAQ
- Drug Manufacturers - Specialty & Generic
- Traditional Chinese Medicine
- Neurocognitive Disorders
$10.05
Today +4.80%Quote Oct 19, 2026, 08:00 PM UTC
+73.58%over the last month
Max drawdown −6.6%From 1-month high 0.0%3 months +65.8%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About Regencell Bioscience
Regencell Bioscience Holdings Limited is a biotechnology firm specializing in Traditional Chinese Medicine (TCM). Its core activities revolve around the research, development, and market introduction of TCM solutions specifically designed to address neurocognitive disorders and related degeneration.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
Employees
10
Market value
$4.98B
Quote Oct 19
Floor
$9.18
8.7% below price
Resistance
$11.53
14.8% above price
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about RGCPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free